/
Other
Drug Interactions
11
Pipeline Programs↗
10
Active Trials↗
44
Companies Involved↗
Drug Interactions is an emerging landscape with 11 programs across 44 companies. The most active players are Daewoong Pharmaceutical Co. LTD., Guangdong Hengrui Pharmaceutical Co., Ltd, Endeavor Biomedicines, Inc..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical1
Phase 110
Phase 2
No programs
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
129
clinical trials
Completed109 · 84%
Unknown status6 · 5%
Recruiting4 · 3%
Active, not recruiting3 · 2%
Not yet recruiting3 · 2%
Terminated2 · 2%
Other2 · 2%
Clinical Trials
Trial Activity
129 trials
Page 1 of 9
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)